Shanghai Lymphoma Clinical Cohort

Shanghai Jiao Tong University

Status: Not yet enrolling

Conditions: Cohort; Lymphoma

Treatments: Other: No interventions need to be specified for this study

Study type: Observational

Funder types: Other

Identifiers

NCT07285174

Shanghai Lymphoma Cohort

Details and patient eligibility

About

The aim of this study is to prospectively collect clinical information on patients with lymphoma, and to explore the best therapeutic strategies in the real-world population.

Full description

Lymphoma is a common hematological malignancy. This study aims to prospectively collect clinical information on patients with lymphoma, including the distribution of involved sites, clinical and molecular characteristics of different lymphoma subtypes, clinical treatment protocols, and prognosis, to explore the best therapeutic strategies in the real-world population.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age ≥ 16 years (including 16 years old).
2. Patients newly diagnosed with non-Hodgkin lymphoma
3. Patients who have received systematic clinical treatment.
4. Patients with measurable lesions, at least containing one effective evaluation of efficacy.

Exclusion criteria

1. Patients who only receive supportive treatment.
2. Patients who cannot obtain effective evaluation data of efficacy.

Trial design

1,000 participants in 1 patient group

Shanghai Lymphoma Clinical Cohort

Description:

Shanghai Lymphoma Clinical Cohort

Treatment:

Other: No interventions need to be specified for this study